Diseases (Basel, Switzerland)
Inclisiran in Dyslipidemia with High Residual Platelet Reactivity.
Dina Kapsultanova, Sholpan Zhangelova, Friba Nurmukhammad, Zulfiya Makasheva, Orazbek Sakhov, Tamara Galkina, Farida Rustamova, Dana Akhmentayeva, Botakoz Aubakirova
Published: 202610.3390/diseases14010030
Abstract
BACKGROUND: High residual platelet reactivity (HRPR) and persistent dyslipidemia remain important unmet needs in cardiovascular risk management, particularly in patients undergoing coronary revascularization. Despite intensive lipid-lowering and anti…
Preview only. Read the full abstract at the source